
Your CBD Store and Small Business Owners Call on Governor Abbott to Veto SB 3, Citing Devastating Economic Consequences
Sunmed™ | Your CBD Store® urges Texas Governor Greg Abbott to Veto Senate Bill 3
AUSTIN, Texas, June 9, 2025 /PRNewswire/ — Sunmed™ | Your CBD Store®, along with its small business hemp retailers across the state, are urging Governor Greg Abbott to veto Senate Bill 3 (SB 3) in account of depriving law-abiding small businesses the opportunity to offer Texans wellness and therapeutic products that foster the Texas economy.
Unless Governor Abbott issues a veto against it, SB 3 will ban most hemp-derived cannabinoid products currently sold at over 7,500 licensed retail establishments throughout Texas. Sunmed | Your CBD Stores are owned by independent small businesses that rely on the sale of legal and wellness hemp-derived cannabinoid products to make a living and support their families.
Ralph Paul, who owns a Sunmed | Your CBD Store in Keller, Texas, warns:
'If SB 3 is signed into law, I'll have no choice but to shut down my businesses. This isn't just about product bans, it's about laying off employees, defaulting on leases, and losing everything we've built. We operate legally and transparently under the Texas Hemp Program. We don't deserve to be collateral damage in a political agenda.'
Across the state, retailers are bracing for closures. Gary Brandt, owner of a Sunmed | Your CBD Store in Lakeway, Texas, adds:
'I've invested my savings, hired local staff, and served customers who depend on our wellness products. This bill doesn't just hurt businesses, it devastates families, communities, and the state's fiscal health. We're urging Governor Abbott to veto SB 3 and stand with small businesses.'
According to the 2025 Economic Impact of Hemp Cannabinoid Processing and Manufacturing on Texas report by Whitney Economics, the hemp-derived cannabinoid industry is a cornerstone of the Texas economy:
53,300 Texans employed $2.1 billion in wages paid $5.5 billion in revenue generated $267 million in retail sales tax contributed $10–10.5 billion total economic impact
The Whitney report underscores that this industry's influence extends beyond storefronts and into rural farming, supply chains, distribution, and manufacturing. Over 8,500 total licenses, spanning retail, wholesale, and manufacturing, will be rendered obsolete.
Sunmed | Your CBD Store and its affiliate network support responsible regulation and consumer safety. However, SB 3 amounts to a prohibition and wipes out a thriving, tax-contributing industry that operates under a clear legal framework.
Call to ActionWe urge all Texans to oppose SB 3. Contact Governor Abbott and request that he veto this harmful legislation:
Call Governor Abbott: (512) 463-2000 Email the Governor: Contact Form Sign the Texas Hemp Business Council Petition: Sign Petition Sign the U.S. Hemp Roundtable Petition: Sign Petition
Sunmed stands with small businesses and the Texas communities they serve. We believe in protecting consumer access to safe, effective hemp products and supporting the local entrepreneurs who provide them. Join us in defending our industry, our economy, and our right to choose.
Contact Patrick ShatzerSunmed l Your CBD Storecustomersupport@getsunmed.com
About Sunmed™ | Your CBD Store® Sunmed | Your CBD Store, an affiliate of Sunflora, Inc., is the largest hemp retailer in the United States and the exclusive home of award-winning, hemp-derived Sunmed products. With 260+ nationwide locations across 39 states, the brand offers a premium in-store customer experience with access to 150+ nonpharmaceutical wellness formulas, including clinically proven sleep gummies, pain relief topicals, USDA-organic oil tinctures, and CBD for pets. Through in-store education, community involvement, and groundbreaking clinical research, Sunmed strives to empower modern wellness and enhance people's lives with natural science-backed products. Learn more at getsunmed.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysian Reserve
6 hours ago
- Malaysian Reserve
Your CBD Store and Small Business Owners Call on Governor Abbott to Veto SB 3, Citing Devastating Economic Consequences
Sunmed™ | Your CBD Store® urges Texas Governor Greg Abbott to Veto Senate Bill 3 AUSTIN, Texas, June 9, 2025 /PRNewswire/ — Sunmed™ | Your CBD Store®, along with its small business hemp retailers across the state, are urging Governor Greg Abbott to veto Senate Bill 3 (SB 3) in account of depriving law-abiding small businesses the opportunity to offer Texans wellness and therapeutic products that foster the Texas economy. Unless Governor Abbott issues a veto against it, SB 3 will ban most hemp-derived cannabinoid products currently sold at over 7,500 licensed retail establishments throughout Texas. Sunmed | Your CBD Stores are owned by independent small businesses that rely on the sale of legal and wellness hemp-derived cannabinoid products to make a living and support their families. Ralph Paul, who owns a Sunmed | Your CBD Store in Keller, Texas, warns: 'If SB 3 is signed into law, I'll have no choice but to shut down my businesses. This isn't just about product bans, it's about laying off employees, defaulting on leases, and losing everything we've built. We operate legally and transparently under the Texas Hemp Program. We don't deserve to be collateral damage in a political agenda.' Across the state, retailers are bracing for closures. Gary Brandt, owner of a Sunmed | Your CBD Store in Lakeway, Texas, adds: 'I've invested my savings, hired local staff, and served customers who depend on our wellness products. This bill doesn't just hurt businesses, it devastates families, communities, and the state's fiscal health. We're urging Governor Abbott to veto SB 3 and stand with small businesses.' According to the 2025 Economic Impact of Hemp Cannabinoid Processing and Manufacturing on Texas report by Whitney Economics, the hemp-derived cannabinoid industry is a cornerstone of the Texas economy: 53,300 Texans employed $2.1 billion in wages paid $5.5 billion in revenue generated $267 million in retail sales tax contributed $10–10.5 billion total economic impact The Whitney report underscores that this industry's influence extends beyond storefronts and into rural farming, supply chains, distribution, and manufacturing. Over 8,500 total licenses, spanning retail, wholesale, and manufacturing, will be rendered obsolete. Sunmed | Your CBD Store and its affiliate network support responsible regulation and consumer safety. However, SB 3 amounts to a prohibition and wipes out a thriving, tax-contributing industry that operates under a clear legal framework. Call to ActionWe urge all Texans to oppose SB 3. Contact Governor Abbott and request that he veto this harmful legislation: Call Governor Abbott: (512) 463-2000 Email the Governor: Contact Form Sign the Texas Hemp Business Council Petition: Sign Petition Sign the U.S. Hemp Roundtable Petition: Sign Petition Sunmed stands with small businesses and the Texas communities they serve. We believe in protecting consumer access to safe, effective hemp products and supporting the local entrepreneurs who provide them. Join us in defending our industry, our economy, and our right to choose. Contact Patrick ShatzerSunmed l Your CBD Storecustomersupport@ About Sunmed™ | Your CBD Store® Sunmed | Your CBD Store, an affiliate of Sunflora, Inc., is the largest hemp retailer in the United States and the exclusive home of award-winning, hemp-derived Sunmed products. With 260+ nationwide locations across 39 states, the brand offers a premium in-store customer experience with access to 150+ nonpharmaceutical wellness formulas, including clinically proven sleep gummies, pain relief topicals, USDA-organic oil tinctures, and CBD for pets. Through in-store education, community involvement, and groundbreaking clinical research, Sunmed strives to empower modern wellness and enhance people's lives with natural science-backed products. Learn more at


Malaysian Reserve
3 days ago
- Malaysian Reserve
Trumid Reports May Performance
Electronic bond trading platform announces record buy-side platform engagement NEW YORK, June 6, 2025 /PRNewswire/ — Trumid, a financial technology company and leading fixed income electronic trading platform, today announced trade volume and user participation highlights for May 2025. May Highlights: May marked another strong month of growth and deepening platform engagement, with record traded volume in Trumid RFQ and accelerating buy-side adoption across Trumid's list trading protocols. Reported Average Daily Volume (ADV) of $6.8B, up 30% year-over-year. A record number of buy-side traders traded daily on Trumid in May, with asset manager ADV up around 60%year-over-year, outpacing growth in overall Trumid volume. Trumid RFQ set another monthly record for volume and trade count, extending its 2025 streak of consecutive month-over-month growth. High response rates from Trumid's fully integrated RFQ responder network of major dealers and leading algorithmic liquidity providers drove protocol ADV and daily average trade count up 122% and 134% year-over-year, respectively. Around 70% more buy-side traders executed trades daily in Trumid RFQ compared to a year ago, with asset managers initiating a record number of lists during the month. Trumid's automated workflow and trade automation tools continued to deliver value for clients. 81% of eligible RFQ line items executed "no touch" via Trumid AutoPilot™ for RFQ in May. Designed for efficient execution, Trumid AutoPilot leverages real-time, client-defined parameters to allow the platform to seamlessly execute trades on their behalf. High response rates from Trumid's fully integrated RFQ responder network of major dealers and leading algorithmic liquidity providers drove protocol ADV and daily average trade count up 122% and 134% year-over-year, respectively. Around 70% more buy-side traders executed trades daily in Trumid RFQ compared to a year ago, with asset managers initiating a record number of lists during the month. Trumid's automated workflow and trade automation tools continued to deliver value for clients. 81% of eligible RFQ line items executed "no touch" via Trumid AutoPilot™ for RFQ in May. Designed for efficient execution, Trumid AutoPilot leverages real-time, client-defined parameters to allow the platform to seamlessly execute trades on their behalf. Trumid press +1 (212) 618-0300 press@ About Trumid Trumid is a financial technology company and fixed income electronic trading platform focused on US dollar-denominated Investment Grade, High Yield, Distressed, and Emerging Market bonds. Trumid optimizes the credit trading experience by combining agile technology and market expertise, with a focus on product design. The result is a differentiated ecosystem of protocols and trading solutions delivered within one intuitive platform. Learn more at © 2025 Trumid Holdings, LLC, and its affiliates. All rights reserved. Trumid Financial, LLC is a broker dealer registered with the U.S. Securities and Exchange Commission ("SEC") and is a member of FINRA and SIPC. Information included in this message does not constitute a trade confirmation or an offer or solicitation of an offer to buy/sell securities or any other products. There is no intention to offer products and services in countries or jurisdictions where such an offer would be unlawful under the relevant domestic law.


Malaysian Reserve
4 days ago
- Malaysian Reserve
Biodefense Market worth $1.81 billion by 2030
DELRAY BEACH, Fla., June 6, 2025 /PRNewswire/ — The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period according to a new report by MarketsandMarkets™. The biodefense market is driven by increasing bioterrorism, growing geopolitical tensions, biological warfare risks, and advancements in technology. Biodefense encompasses a range of tools and systems designed to detect, prevent, and respond to biological threats, including infectious diseases, bioterrorism, and accidental pathogen releases. These include biosensors, rapid detection platforms, decontamination systems, mobile containment units, and AI-driven surveillance tools. The market for biodefense technology is experiencing strong growth due to increasing global concerns over pandemics, biological warfare, and emerging infectious diseases. Download PDF Brochure: Browse in-depth TOC on 'Biodefense Market' 196 – Tables56 – Figures217 – Pages Biodefense Market Report Scope: Report Coverage Details Market Revenue in 2025 $ 0.89 billion Estimated Value by 2030 $ 1.81 billion Growth Rate Poised to grow at a CAGR of 15.1% Market Size Available for 2020–2030 Forecast Period 2025–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By Technology, Product, Application and Region Geographies Covered North America, Europe, Asia Pacific, and Rest of World Key Market Challenge Infrastructure constraints in low-resource areas Key Market Opportunities Emergence of AI-powered biosurveillance and predictive analytics Key Market Drivers Rising threat of Bioterrorism Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Hospitals are the initial point of contact for the identification of unusual infections or exposure to biological agents, and hence, they must have sophisticated containment systems, sterilization apparatus, and pathogen detection instruments in real time. With increasing bioterrorism, governments and health agencies are investing heavily in the upgrade of hospital biosafety facilities, such as Class III biological safety cabinets, mobile isolation units, and UV sterilization technology, all of which are becoming essential for modern biodefense infrastructure. These facilities need safe conditions to work with high-risk pathogens, which fuels the demand for low-temperature sterilizers, decontamination chambers, and air purification. The growing incorporation of digital surveillance platforms and smart biodefense technologies in healthcare facilities further solidifies their role in early detection and quick response, making hospitals & medical institutes the largest application segment of the biodefense market. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period due to its significant contributions toward monitoring real-time pathogens, forecasting, and fast decision-making. AI facilitates the convergence and synthesis of large-scale environmental data and enables early threat detection and quick response coordination. Governments and health organizations globally are increasingly using AI platforms to track bio-threats across borders and to automatically report disease transmission for strategic purposes. Additionally, AI technologies are being integrated into biosensor networks, autonomous disinfecting robots, and predictive modeling applications utilized in hospitals, airports, and military bases. The increasing focus on digitally empowered biodefense infrastructure, coupled with significant investments by public and private sectors, is expected to fuel the growth of the AI segment in the global market. Inquiry Before Buying: Asia Pacific is projected to register the highest CAGR during the forecast period. Asia Pacific is projected to register the highest CAGR in the biodefense industry through the forecast period due to increasing investments in public health infrastructure, infectious disease surveillance, and military biosafety capacities. China, India, Japan, and Australia are comprehensively developing their biodefense capabilities. These countries are investing in mobile biosafety laboratories, near-real-time pathogen detection systems, and next-generation decontamination technologies to anticipate future biological threats. Also, the region is experiencing growth in biotechnology R&D, cross-border health security efforts, and government-backed biodefense programs. The growth of local biotech and med-tech firms is also propelling innovation in AI-powered disease monitoring, biosensors, and portable sterilizers for civilian and military applications. The growing population, susceptibility to zoonotic disease, and proactive policy changes are driving significant growth in the regional biodefense market. STERIS (US), ASP International GmbH (a subsidiary of Fortive) (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the major key players in the biodefense companies. These companies have strong distribution networks across regions like North America, Europe, Asia Pacific, and the Rest of the World. Get 10% Free Customization on this Report: Browse Adjacent Market: Aerospace and Defence Market Research Reports & Consulting Related Reports: Border Security Market by Domain (Land, Maritime, Airborne), Vertical (Military, Homeland Security), System (Surveillance Systems, Detection Systems, Communication Systems, Command and Control Systems), Installation & Region – Global Forecast to 2029 CBRN Defense Market by Type (Chemical, Biological, Radiological, Nuclear, Explosives), Equipment (Protective Wearables, Respiratory Systems, Detection & Monitoring Systems, Decontamination Systems, Simulators, Others), End Use and Region – Global Forecast to 2028 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC. 1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Web Site: Insight: Source: Logo: View original content: